ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Macrophage Dab1 Links Early Hypoxia to Adaptive Angiogenesis to Drive Peripheral Nerve Repair.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Effective nerve regeneration depends on the precise spatiotemporal coordination of immune responses and adaptive angiogenesis, often driven by injury-induced hypoxia. However, how early hypoxic signals are sensed and translated into vascular niches remains poorly understood. Using peripheral nerve injury as a model, we show that hypoxia exerts stage-specific functions dictating regenerative outcomes. Suppressing the early hypoxic response by premature oxygen supplementation lowers HIF-1α, attenuates angiogenesis, and ultimately compromises long-term regeneration, whereas prolonged hypoxia ex vivo causes axonal and myelin injury. Using spatiotemporal hypoxia mapping, genetic mouse models, and human nerve specimens, we identify Disabled-1 (Dab1) as a previously unrecognized hypoxia-responsive adaptor that is prominently induced in macrophages and links hypoxia to angiogenesis. Macrophage-specific Dab1 deletion diminishes HIF-1α/VEGF-A signaling, impairs vascular remodeling, and delays nerve regeneration, whereas enhancing Dab1 signaling improves the regenerative microenvironment. Mechanistically, Dab1 sustains hypoxia-associated HIF-1α accumulation, partially through the Na
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.